Ribavirin

This classification denotes an antiviral agent with the molecular formula C8H12N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49717AWG6K, chemically known as 1,2,4-triazole-3-carboxamide, 1-.beta.-d-ribofuranosyl- but generally known as ribavirin, which bears US NIH Compound Identifier 5064. European Medicines Agency schedules Ribavirin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10297MIG. The term RIBAVIRIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules ribavirin in its Anatomical Therapeutic Chemical (ATC) Classification. RIBAVIRIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ribavirin under HS 29349990 and SITC 51579. As of Q4 2014, RIBAVIRIN remains the US FDA Preferred Term for this commodity. Ribavirin bears US NLM identifiers UMLS ID C0035525 and NCI Concept Code C807. SMILES: O1C(C(O)C(O)C1N1NC(NC1)C(=O)N)CO.